Nitric oxide therapy is an effective, FDA-approved method to treat conditions like hypoxic respiratory failure with pulmonary hypertension in newborns ages 34 weeks and older. Share on Pinterest Jill ...
Low doses of inhaled nitric oxide can decrease the risk of chronic lung disease and death by nearly one-fourth in premature infants who have respiratory distress syndrome (RDS), report researchers ...
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback